P53 Tumor

Maureen E. Murphy, PhD, has been appointed deputy director of Ellen and Ronald Caplan Cancer Center at The Wistar Institute.

Matthew S. Davids, MD, MMSc, of Dana-Farber Cancer Institute, explored clinical data on targeting p53-mutant hematologic malignancies in the presidential symposium at the ASH Annual Meeting and Exposition.